These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15832557)

  • 1. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.
    Meletiadis J; Verweij PE; TeDorsthorst DT; Meis JF; Mouton JW
    Med Mycol; 2005 Mar; 43(2):133-52. PubMed ID: 15832557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
    Meletiadis J; Mouton JW; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2003 Jan; 47(1):106-17. PubMed ID: 12499177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates.
    Te Dorsthorst DT; Verweij PE; Meis JF; Punt NC; Mouton JW
    Antimicrob Agents Chemother; 2002 Mar; 46(3):702-7. PubMed ID: 11850251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.
    Te Dorsthorst DT; Verweij PE; Meis JF; Punt NC; Mouton JW
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2007-13. PubMed ID: 15155192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole.
    Afeltra J; Vitale RG; Mouton JW; Verweij PE
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1335-43. PubMed ID: 15047538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Collaborative Study of the Interaction of Antifungal Combinations against
    Meletiadis J; Andes DR; Lockhart SR; Ghannoum MA; Knapp CC; Ostrosky-Zeichner L; Pfaller MA; Chaturvedi V; Walsh TJ
    J Fungi (Basel); 2022 Sep; 8(9):. PubMed ID: 36135692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.
    Meletiadis J; te Dorsthorst DT; Verweij PE
    Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
    Meletiadis J; Stergiopoulou T; O'Shaughnessy EM; Peter J; Walsh TJ
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2053-64. PubMed ID: 17387150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of antifungal combinations against yeasts and dermatophytes.
    Harman S; Ashbee HR; Evans EG
    J Dermatolog Treat; 2004 Apr; 15(2):104-7. PubMed ID: 15204161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG; Sesli Çetin E; Ozseven L
    Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
    Rudramurthy SM; Jatana M; Singh R; Chakrabarti A
    Mycoses; 2013 Jan; 56(1):39-46. PubMed ID: 22519679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
    Yekutiel A; Shalit I; Shadkchan Y; Osherov N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of some essential oils against fungal spoilage on pear fruit.
    Nikkhah M; Hashemi M; Habibi Najafi MB; Farhoosh R
    Int J Food Microbiol; 2017 Sep; 257():285-294. PubMed ID: 28763743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
    Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
    J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study.
    Jessup C; Reyes G; Fothergill A; McCarthy D; Rinaldi M; Messer S; Pfaller M; Ghannoum M
    J Chemother; 2000 Feb; 12(1):22-9. PubMed ID: 10768512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of in vitro synergy when amphotericin B is combined with various antimicrobial agents against yeasts by using a colorimetric microdilution checkerboard].
    Yamane N; Behiry IK; Tosaka M; Nakasone I
    Rinsho Byori; 1997 Jul; 45(7):689-95. PubMed ID: 9256018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison Between Etest and Broth Microdilution Methods for Testing Itraconazole-Resistant Aspergillus fumigatus Susceptibility to Antifungal Combinations.
    Denardi LB; Keller JT; de Azevedo MI; Oliveira V; Piasentin FB; Severo CB; Santurio JM; Alves SH
    Mycopathologia; 2018 Apr; 183(2):359-370. PubMed ID: 28994001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.